Tumour necrosis factor analogues
Latest Information Update: 15 Aug 2002
At a glance
- Originator Nonindustrial source; Roche
- Developer Roche
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer